ME00986B - Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom - Google Patents

Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Info

Publication number
ME00986B
ME00986B MEP-2010-54A MEP5410A ME00986B ME 00986 B ME00986 B ME 00986B ME P5410 A MEP5410 A ME P5410A ME 00986 B ME00986 B ME 00986B
Authority
ME
Montenegro
Prior art keywords
ivabradine
addition salts
synthesiis
acid
new process
Prior art date
Application number
MEP-2010-54A
Other languages
English (en)
Inventor
Jean-Louis Peglion
AIMéE DESSINGES
Bernard Serkiz
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40983371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00986(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of ME00986B publication Critical patent/ME00986B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Postupak sinteze ivabradina formule (I) :   i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom.  
MEP-2010-54A 2009-03-31 2009-03-31 Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom ME00986B (me)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901556A FR2943668B1 (fr) 2009-03-31 2009-03-31 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Publications (1)

Publication Number Publication Date
ME00986B true ME00986B (me) 2012-06-20

Family

ID=40983371

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-54A ME00986B (me) 2009-03-31 2009-03-31 Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom

Country Status (35)

Country Link
US (1) US8119794B2 (me)
EP (1) EP2241553B1 (me)
JP (1) JP5107381B2 (me)
KR (1) KR101166632B1 (me)
CN (1) CN101851204B (me)
AR (1) AR075978A1 (me)
AT (1) ATE517093T1 (me)
AU (1) AU2010201035B2 (me)
BR (1) BRPI1000865A2 (me)
CA (1) CA2697563C (me)
CL (1) CL2010000253A1 (me)
CY (1) CY1111914T1 (me)
DK (1) DK2241553T3 (me)
EA (1) EA016353B1 (me)
ES (1) ES2370150T3 (me)
FR (1) FR2943668B1 (me)
GE (1) GEP20125446B (me)
HK (1) HK1148749A1 (me)
HR (1) HRP20110683T1 (me)
JO (1) JO2781B1 (me)
MA (1) MA31746B1 (me)
ME (1) ME00986B (me)
MX (1) MX2010003213A (me)
MY (1) MY150014A (me)
NZ (1) NZ584310A (me)
PE (1) PE20110098A1 (me)
PL (1) PL2241553T3 (me)
RS (1) RS51920B (me)
SA (1) SA110310239B1 (me)
SI (1) SI2241553T1 (me)
TW (1) TWI376371B (me)
UA (1) UA105894C2 (me)
UY (1) UY32499A (me)
WO (1) WO2010112705A1 (me)
ZA (1) ZA201002120B (me)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471780B1 (en) * 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2471780B1 (en) 2007-05-30 2014-11-26 Ind-Swift Laboratories Limited Crystalline Ivabradine Oxalate Salts and Polymorphs Thereof

Also Published As

Publication number Publication date
FR2943668A1 (fr) 2010-10-01
EP2241553A1 (fr) 2010-10-20
CN101851204A (zh) 2010-10-06
US20100249398A1 (en) 2010-09-30
CN101851204B (zh) 2013-02-13
FR2943668B1 (fr) 2011-05-06
EP2241553B1 (fr) 2011-07-20
EA201000398A1 (ru) 2010-12-30
MY150014A (en) 2013-11-15
US8119794B2 (en) 2012-02-21
KR101166632B1 (ko) 2012-07-19
NZ584310A (en) 2010-11-26
PE20110098A1 (es) 2011-03-02
AU2010201035A1 (en) 2010-10-14
ZA201002120B (en) 2010-11-24
UY32499A (es) 2010-09-30
HRP20110683T1 (hr) 2011-10-31
CY1111914T1 (el) 2015-11-04
TW201041854A (en) 2010-12-01
AU2010201035B2 (en) 2015-03-19
TWI376371B (en) 2012-11-11
JO2781B1 (en) 2014-03-15
JP2010241808A (ja) 2010-10-28
GEP20125446B (en) 2012-03-26
BRPI1000865A2 (pt) 2012-01-17
HK1148749A1 (en) 2011-09-16
CA2697563C (fr) 2012-05-15
KR20100109527A (ko) 2010-10-08
CA2697563A1 (fr) 2010-09-30
MX2010003213A (es) 2010-10-05
PL2241553T3 (pl) 2011-11-30
RS51920B (en) 2012-02-29
SI2241553T1 (sl) 2011-10-28
MA31746B1 (fr) 2010-10-01
ES2370150T3 (es) 2011-12-13
ATE517093T1 (de) 2011-08-15
CL2010000253A1 (es) 2011-04-25
EA016353B1 (ru) 2012-04-30
UA105894C2 (uk) 2014-07-10
JP5107381B2 (ja) 2012-12-26
AR075978A1 (es) 2011-05-11
SA110310239B1 (ar) 2014-03-02
DK2241553T3 (da) 2011-10-31
WO2010112705A1 (fr) 2010-10-07

Similar Documents

Publication Publication Date Title
JO2807B1 (en) A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid.
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
ME00986B (me) Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
MY169295A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ME00987B (me) Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom
JO2930B1 (en) A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX349425B (es) Nuevo procedimiento de sintesis del 3-(2-bromo-4,5-dimetoxifenil) propanonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
SA113340412B1 (ar) عملية جديدة لتصنيع إيڤابرادين وأملاح إضافة منه مع حمض مقبول صيدلانياً
MY160928A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid